Hassan Muhammad Radzi Abu, Suan Mohd Azri Mohd, Soelar Shahrul Aiman, Mohammed Noor Syahireen, Ismail Ibtisam, Ahmad Faizah
Clinical Research Center, Clinical Research Center, Hospital Sultanah Bahiyah, Kedah, Malaysia Email :
Asian Pac J Cancer Prev. 2016;17(7):3575-81.
Cancer survival analysis is an essential indicator for effective early detection and improvements in cancer treatment. This study was undertaken to document colorectal cancer survival and associated prognostic factors in Malaysians.
All data were retrieved from the National Cancer Patient Registry Colorectal Cancer. Only cases with confirmed diagnosis through histology between the year 2008 and 2009 were included. Retrieved data include sociodemographic information, pathological features and treatment received. Survival curves were plotted using the KaplanMeier method. Univariate analysis of all variables was then made using the Logrank test. All significant factors that influenced survival of patients were further analysed in a multivariate analysis using Cox' regression.
Total of 1,214 patients were included in the study. The overall 3 and 5year survival rates were 59.1% and 48.7%, respectively. Patients with localized tumours had better prognosis compared to those with advanced stage cancer. In univariate analysis, staging at diagnosis (p<0.001), primary tumour size (p<0.001), involvement of lymph nodes (p<0.001) and treatment modalities (p=0.001) were found to be predictors of survival. None of the sociodemographic characteristics were found to exert any influence. In Cox regression analysis, staging at diagnosis (p<0.001), primary tumour size (p<0.001), involvement of lymph nodes (p<0.001) and treatment modalities (p<0.001) were determined as independent prognostic factors of survival after adjusted for age, gender and ethnicity.
The overall survival rate for colorectal cancer patients in Malaysia is similar to those in other Asian countries, with staging at diagnosis, primary tumor size, involvement of lymph node and treatment modalities having significant effects. More efforts are needed to improve national survival rates in future.
癌症生存分析是有效早期检测和改善癌症治疗的重要指标。本研究旨在记录马来西亚结直肠癌患者的生存情况及相关预后因素。
所有数据均取自国家癌症患者登记处的结直肠癌数据。仅纳入2008年至2009年间经组织学确诊的病例。检索到的数据包括社会人口统计学信息、病理特征和接受的治疗。使用Kaplan-Meier方法绘制生存曲线。然后使用Logrank检验对所有变量进行单因素分析。对所有影响患者生存的显著因素,在多因素分析中使用Cox回归进一步分析。
本研究共纳入1214例患者。总体3年和5年生存率分别为59.1%和48.7%。局限性肿瘤患者的预后优于晚期癌症患者。在单因素分析中,诊断时的分期(p<0.001)、原发肿瘤大小(p<0.001)、淋巴结受累情况(p<0.001)和治疗方式(p=0.001)被发现是生存的预测因素。未发现社会人口统计学特征有任何影响。在Cox回归分析中,在对年龄、性别和种族进行调整后,诊断时的分期(p<0.001)、原发肿瘤大小(p<0.001)、淋巴结受累情况(p<0.001)和治疗方式(p<0.001)被确定为生存的独立预后因素。
马来西亚结直肠癌患者的总体生存率与其他亚洲国家相似,诊断时的分期、原发肿瘤大小、淋巴结受累情况和治疗方式有显著影响。未来需要做出更多努力来提高全国生存率。